Sign In
Buy RGEN
$149.78
+2.72 (+1.85%)
At Close: Aug 04, 2026
Checking In on 10 Stock Picks
10:00am, Saturday, 17'th Sep 2022
Five stocks indistinguishable from magic and five stocks with a tailwind blow.
Why Medical Products Maker Repligen May Be A Potential Buy
10:23am, Thursday, 15'th Sep 2022
Medical products maker Repligen has a long history of trouncing sales and earnings views, and it just boosted its full-year sales guidance. Is the stock a buy?
2 Top Healthcare Stocks to Buy for September
02:15pm, Thursday, 08'th Sep 2022 The Motley Fool
These companies bring different strengths and opportunities to a stock portfolio.
These 3 Stocks Are the Future of Biotechnology
02:36pm, Sunday, 04'th Sep 2022 The Motley Fool
Here's why three Fool.com contributors love Vertex Pharmaceuticals, Repligen, and Recursion Pharmaceuticals.
These 3 Stocks Are the Future of Biotechnology
10:36am, Sunday, 04'th Sep 2022
Here's why three Fool.com contributors love Vertex Pharmaceuticals, Repligen, and Recursion Pharmaceuticals.
Repligen (RGEN) Down 8.8% Since Last Earnings Report: Can It Rebound?
03:31pm, Thursday, 01'st Sep 2022 Zacks Investment Research
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Repligen (RGEN) Down 8.8% Since Last Earnings Report: Can It Rebound?
01:09pm, Thursday, 01'st Sep 2022
Repligen (RGEN) reported earnings 30 days ago. What's next for the stock?
Repligen To Host Investor Day 2022
11:30am, Wednesday, 24'th Aug 2022 GlobeNewswire Inc.
WALTHAM, Mass., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a leading innovator of bioprocessing technologies and solutions, today announced that it will host “Repligen I
Here's Why Repligen (RGEN) is a Strong Growth Stock
01:45pm, Wednesday, 17'th Aug 2022 Zacks Investment Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Repligen (RGEN) is a Strong Growth Stock
11:17am, Wednesday, 17'th Aug 2022
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Catalent-Repligen Merger 'Seems Unlikely,' This Analyst Says
10:30pm, Friday, 12'th Aug 2022 Benzinga
Yesterday, Catalent Inc (NYSE: CTLT) announced to acquire Metrics Contract Services for $475 million.
Keybanc notes that the deal strengthens CTLT's oral delivery portfolio and targets rapidly gro
Why Shares of Repligen Surged This Week
05:57pm, Thursday, 04'th Aug 2022 The Motley Fool
The bioprocessing equipment company is seeing growth prospects accelerate for its non-COVID-related revenue.
Why Shares of Repligen Surged This Week
01:57pm, Thursday, 04'th Aug 2022
The bioprocessing equipment company is seeing growth prospects accelerate for its non-COVID-related revenue.
Repligen (RGEN) Q2 Earnings and Sales Beat Estimates, Stock Up
04:19pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Repligen (RGEN) reports encouraging second-quarter results, with sales and earnings beating estimates. RGEN also raises its financial guidance for 2022
Expert Ratings for Repligen
04:09pm, Wednesday, 03'rd Aug 2022 Benzinga
Analysts have provided the following ratings for Repligen (NASDAQ:RGEN) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
3
0
0
0
Last 3
